BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//PlainTrial//Saved Trials Calendar//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:PlainTrial saved trials
X-WR-CALDESC:Estimated completion dates for the clinical trials you saved o
 n PlainTrial.
BEGIN:VEVENT
UID:plaintrial-NCT06082167-completion@plaintrial.com
DTSTAMP:20261027T200631Z
DTSTART;VALUE=DATE:202903
SUMMARY:Study of Zanzalintinib (XL092) + Pembrolizumab vs Pembrolizumab in 
 Subjects With PD-L1 Positive Recurrent or Metastatic Head and Neck Squamou
 s Cell Carcinoma — estimated completion date
DESCRIPTION:Active\, not recruiting. Saved on your PlainTrial shortlist. Fu
 ll trial record: https://plaintrial.com/trial/NCT06082167
URL:https://plaintrial.com/trial/NCT06082167
END:VEVENT
END:VCALENDAR